PapersFlow Research Brief
Advanced Glycation End Products research
Research Guide
What is Advanced Glycation End Products research?
Advanced Glycation End Products research is the study of the biochemistry and molecular cell biology of diabetic complications, focusing on the role of Advanced Glycation End Products (AGEs), HMGB1, oxidative stress, inflammation, and the receptor for AGEs (RAGE).
This field encompasses 45,844 works examining AGEs alongside mitochondrial superoxide, toll-like receptors, necrotic cells, and cellular signaling pathways in diabetes pathobiology. Michael Brownlee (2001) showed that metabolic abnormalities in diabetes cause mitochondrial superoxide overproduction in endothelial cells, leading to microvascular and cardiovascular complications. Ferdinando Giacco and Michael Brownlee (2010) demonstrated that oxidative stress from this overproduction drives damage in both large and small vessels as well as the myocardium.
Topic Hierarchy
Research Sub-Topics
Advanced Glycation End Products in Diabetes
This sub-topic details AGE formation pathways from hyperglycemia, tissue accumulation patterns, and contributions to vascular complications. Biochemical assays quantify AGE-RAGE interactions in diabetic cohorts.
RAGE Signaling in Diabetic Pathobiology
Research maps receptor for AGE downstream cascades activating NF-κB, MAPK, and STAT pathways in endothelial dysfunction. Knockout models demonstrate RAGE's necessity in nephropathy and retinopathy development.
Mitochondrial Superoxide in Hyperglycemic Damage
Studies link electron transport chain superoxide overproduction to PKC, hexosamine, and AGE flux activation in hyperglycemia. Antioxidant interventions test causality in vascular cell models.
HMGB1 in Diabetic Inflammation
This area examines high-mobility group box 1 release from necrotic beta cells and its amplification of sterile inflammation via TLR4/RAGE. Serum profiling correlates HMGB1 with complication severity.
Oxidative Stress Mechanisms in Diabetic Complications
Comprehensive reviews integrate ROS sources, antioxidant defenses, and downstream effectors like polyol pathway flux in neuropathy, retinopathy, and cardiomyopathy. Longitudinal studies link oxidative markers to progression.
Why It Matters
Advanced Glycation End Products research identifies mechanisms underlying diabetic complications, with direct applications in managing microvascular and cardiovascular diseases. John Baynes (1991) detailed how glycoxidation products like Nϵ-(carboxymethyl)lysine, Nϵ-(carboxymethyl)hydroxylysine, and pentosidine accumulate in tissue collagen at accelerated rates in diabetes, contributing to complications. "Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children" by Anshu Gupta and Jaime Uribarri (2016) linked dietary AGEs to inflammation, insulin resistance, and oxidative stress in rising cases of obesity, diabetes, and cardiovascular disease among adolescents, with 4017 citations highlighting its relevance to pediatric cardiometabolic health.
Reading Guide
Where to Start
'Biochemistry and molecular cell biology of diabetic complications' by Michael Brownlee (2001) provides the foundational overview of AGEs, RAGE, oxidative stress, and inflammation in diabetes pathobiology, making it the ideal starting point with 8903 citations.
Key Papers Explained
Michael Brownlee (2001) in 'Biochemistry and molecular cell biology of diabetic complications' establishes the core mechanisms of AGEs and RAGE in diabetes. Ferdinando Giacco and Michael Brownlee (2010) build on this in 'Oxidative Stress and Diabetic Complications' by detailing mitochondrial superoxide overproduction as the driver of vascular damage. Takeshi Nishikawa et al. (2000) extend these findings in 'Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage', showing normalization prevents key pathways. John Baynes (1991) provides biochemical origins in 'Role of Oxidative Stress in Development of Complications in Diabetes', linking glycoxidation products to tissue accumulation.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research continues to explore AGEs in neuroinflammation, as in 'Neuroinflammation in Alzheimer's disease' by Michael T. Heneka et al. (2015), potentially linking diabetes mechanisms to neurodegeneration. Dietary AGEs effects in children from Anshu Gupta and Jaime Uribarri (2016) suggest ongoing focus on prevention strategies. No recent preprints or news available indicate steady maturation without major shifts.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Biochemistry and molecular cell biology of diabetic complications | 2001 | Nature | 8.9K | ✕ |
| 2 | Neuroinflammation in Alzheimer's disease | 2015 | The Lancet Neurology | 5.7K | ✓ |
| 3 | Oxidative Stress and Diabetic Complications | 2010 | Circulation Research | 5.2K | ✓ |
| 4 | Normalizing mitochondrial superoxide production blocks three p... | 2000 | Nature | 4.2K | ✕ |
| 5 | Release of chromatin protein HMGB1 by necrotic cells triggers ... | 2002 | Nature | 4.1K | ✕ |
| 6 | Vagus nerve stimulation attenuates the systemic inflammatory r... | 2000 | Nature | 4.0K | ✕ |
| 7 | Dietary Advanced Glycation End Products and Their Potential Ro... | 2016 | Hormone Research in Pa... | 4.0K | ✓ |
| 8 | Role of Oxidative Stress in Development of Complications in Di... | 1991 | Diabetes | 3.7K | ✕ |
| 9 | HMG-1 as a Late Mediator of Endotoxin Lethality in Mice | 1999 | Science | 3.4K | ✕ |
| 10 | Resveratrol Reduces the Proinflammatory Effects and Lipopolysa... | 2014 | Cellular Physiology an... | 3.3K | ✓ |
Frequently Asked Questions
What role does mitochondrial superoxide play in diabetic complications?
Metabolic abnormalities of diabetes cause mitochondrial superoxide overproduction in endothelial cells of large and small vessels as well as in the myocardium. This overproduction drives oxidative stress pivotal to both microvascular and cardiovascular complications. Ferdinando Giacco and Michael Brownlee (2010) established this mechanism in 'Oxidative Stress and Diabetic Complications'.
How are Advanced Glycation End Products formed?
AGEs form through sequential glycation and oxidation reactions between reducing sugars and proteins, yielding compounds like Nϵ-(carboxymethyl)lysine, Nϵ-(carboxymethyl)hydroxylysine, and pentosidine. These glycoxidation products accumulate in tissue collagen with age and at accelerated rates in diabetes. John Baynes (1991) described this process in 'Role of Oxidative Stress in Development of Complications in Diabetes'.
What is the connection between HMGB1 and inflammation?
HMGB1 released by necrotic cells triggers inflammation, acting as a late mediator in endotoxin lethality by stimulating macrophages to release TNF and IL-1. Haichao Wang et al. (1999) showed HMGB1's role in endotoxemia in 'HMG-1 as a Late Mediator of Endotoxin Lethality in Mice'. Paola Scaffidi, Tom Misteli, and Marco E. Bianchi (2002) confirmed this in 'Release of chromatin protein HMGB1 by necrotic cells triggers inflammation'.
How does normalizing mitochondrial superoxide affect hyperglycemic damage?
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage in diabetes. Takeshi Nishikawa et al. (2000) demonstrated this effect in 'Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage', preventing complications linked to oxidative stress. The study used interventions to target superoxide in endothelial cells.
What is the role of RAGE in AGEs-related pathology?
RAGE, the receptor for AGEs, mediates signaling pathways activated by AGEs binding, contributing to inflammation and diabetic complications. This cluster of 45,844 papers highlights RAGE's involvement alongside oxidative stress and toll-like receptors in diabetes pathobiology. Michael Brownlee (2001) outlined these interactions in 'Biochemistry and molecular cell biology of diabetic complications'.
Open Research Questions
- ? How do interactions between AGEs, RAGE, and toll-like receptors amplify mitochondrial superoxide production in specific diabetic tissues?
- ? What are the precise downstream cellular signaling pathways linking HMGB1 release from necrotic cells to chronic inflammation in diabetes?
- ? Can targeted inhibition of RAGE or HMGB1-TLR4 signaling prevent accumulation of glycoxidation products like pentosidine in vascular collagen?
- ? How does dietary AGE intake modulate oxidative stress pathways in pediatric populations at risk for cardiometabolic disease?
- ? What mechanisms allow vagus nerve stimulation to attenuate HMGB1-mediated systemic inflammation in diabetic complications?
Recent Trends
The field maintains 45,844 works with no specified 5-year growth rate, reflecting sustained interest in AGEs, RAGE, and oxidative stress in diabetes.
Citation leaders like Michael Brownlee (2001, 8903 citations) and Ferdinando Giacco and Michael Brownlee (2010, 5241 citations) underscore persistent focus on mitochondrial superoxide pathways.
No recent preprints or news in the last 12 months signals stable progress without new disruptions.
Research Advanced Glycation End Products research with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Advanced Glycation End Products research with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers